Featuring
By considering all possible avenues of dispute risk from the outset of a project, proponents can minimize the impact and duration of litigation related to plans and permits. Dennis Mahony and Jon Silver explain how to apply a “litigation lens” to major projects to mitigate legal risk and expedite project development.
Dennis Mahony (00:13): Hi, everybody. My name is Dennis Mahony. I'm the head of our environmental health and safety group, and I'm joined by my litigator colleague, Jon Silver. Both of us work regularly on major projects, and major projects permitting in particular. And Jon is going to introduce what this short video will be about. Jon?
Jon Silver (00:31): Yeah, well we are doing our video series on navigating project disputes. And our focus today is on permitting. When you think of a permitting dispute after a major project approval is issued, you know, you tend to think about injunctions or appeals, or judicial reviews. And our colleagues, Andrew and Yael, are going to speak about those types of messy conflicts in another video in this series.
Today, we're going to start much earlier and discuss the importance of applying a litigation lens from the beginning of the project. So, Dennis, why don't you explain what we mean when we say “litigation lens”?
Dennis Mahony (01:10): Yeah, happy to do it, Jon. “Litigation lens” is our own catch phrase. We invented it. We haven't trademarked it, but we're happy to use it. And others at different firms will have different names for it. It's our short form for building a consideration of future potential litigation into the project planning process. So one of many objectives, for example, in building a planning -- and planning a facility, might be, for the building, to withstand a 100-year storm event.
So for major projects, withstanding litigation risk needs to be added to that kind of list early on. You don't wait until your building foundation is leaking to begin thinking about storm event risk mitigation. Litigation risk is the same. If you don't think about it early, you're not able to take those mitigative steps in order to reduce the risk.
So the goal in applying the lens really is threefold. First one, identify early on the kind of litigation challenges that the project might face. And that is in order to minimize the risk that they'll ever be filed. But in a major project, that's a tough ask. What you're really doing is trying to minimize the risk that that litigation will be successful and cause a major source of delay.
Jon Silver (02:31): And so what are some of the examples of how you apply a litigation lens early on in the project?
Dennis Mahony (02:36): Well, Jon, I'm going to give you two examples that I know you're familiar with. And they'll seem counterintuitive to some folks at first. The first is in the area of project location or design planning. The second example I'll give is with respect to technical or expert reporting. And on the face of it, both of these areas are the obvious preserve of engineers and subject matter experts.
So let's talk about the first one. I'll give you an example of routing. For example, one of the projects we're working on now, routing a major linear project, let's say a highway or a transmission line. The engineers come across some endangered species’ habitat when they're plotting out what the route is going to look like. They huddle with their environmental experts, and together they decide they'll apply for a permit and press on.
Now, what we do in that circumstance, Jon, is, you know, as we say, just a minute, let's apply the litigation lens, to determine the likelihood and strength of potential legal challenges on that scenario. And to think very carefully about what project delays might arise as a result.
So one outcome of the application of that lens is that the engineering and project team thank us for our input, and decide that it actually makes sense to steer around that endangered species’ habitat. Another is that the team decides it will stay the course, but they now fully appreciate the risk and they can build that into the schedule. So that's the first example. The second example’s another one I'll pick up on the same line is, let's go to the technical reporting.
In your application processes, as you know, Jon, you'd have to file a species at risk report on the actual subject. The species, let's use an example, is, we get a turtle expert, who's engaged in filing the report. Experienced project lawyers know that application filings like that regularly become very important exhibits in litigation. And we just had a ruling very recently which is heavily focused on that particular species.
So most technical experts, when they're drafting those reports, they don't think about that: litigation that may be years in the future is the furthest thing from their mind. So we, with a very light touch, as you know, like to look at those reports and just see that they're crafted in a way that not just a technical audience can absorb them, but also a court can absorb them.
And I know, Jon, you spend a lot of time doing exactly that. So, why don't you talk for a minute about what happens to those reports, once they get in front of a court?
Jon Silver (05:22): Yeah. So, you're right, Dennis, those reports get filed with the approval authority. And once that issue gets to the court, those reports are what the court considers. You don't get to revise them when the litigation commences three years later. And so, even if at the approval stage, your audience is the approval authority, you have to be thinking about your audience being the court as well.
Now, an approval authority or an environmental panel may have a deep expertise in the issues that you're filing your report about. And that's going to help them wade through dense subject matter, understand exactly how the issues might affect the, you know, the turtle species at risk, but a judge won't have that expertise. So applying a litigation lens early can help you ensure that the materials you file have enough detail to satisfy the subject matter expert, but also include enough plain language that it can speak to a judge as well. You can include summaries, overviews that help the reader digest that material.
Dennis Mahony (06:27): Yeah, and Jon, in my experience, and yours as well, I know, it's very surprising how a light touch when the report is being drafted makes so much of a difference in the litigation to come. Why, why don't you talk a little bit about what kind of lawyer is best suited to work on the permits and to apply the litigation lens.
Jon Silver (06:48): Well, you know, we work in teams at Torys, and our best scenario is one where we have a team that has regulatory experts in the approval regime and also experts with litigation expertise. Sometimes that's one lawyer, but more often than not, especially on the big projects, it's a combination of team members. So, when a big project approval file comes in, you know, we usually have a litigator on the file right from the outset because litigators like me spend all day, every day on written and oral advocacy.
So, for a litigator, applying a perspective of "how is a judge going to read this" is sort of automatic. So, but I also work on regulatory matters daily. And so, I can understand the issue from a regulatory perspective. But I can also apply that litigation lens to it. Another thing that litigators sort of bring to the table is that we understand on both a granular level and sort of at a broader level the type of court cases that may lie ahead.
And we've worked on many cases where the project approval team, the project approval has been challenged by a project opponent and having a litigator involved to understand the issues that a court may eventually consider really helps flag risks and decision points far out enough in advance that they can be addressed, early enough that, you know, when it gets to the court, you've already dealt with it.
Dennis Mahony (08:13): Yeah. And why don't you address – that's all super important. And I think we are certainly one of the firms who brings in our litigation team very early. Oftentimes litigators aren't seen on these projects until after the storm breaks out. So why don't you, to put a point of emphasis on this, tell us why you like to be involved for years before the actual litigation breaks out?
Jon Silver (08:41): You know, ultimately, if you're going to defend an approval, there's no better way to increase your chances of success than to be on the ground developing the record, in front of the approval authority. So, as I mentioned, you can't revise the filing once it goes before the court, you're stuck with those materials and, you know, whether the environmental assessment panel looked at it or not, that's going to be what's before the court.
And so, in my experience, it's much easier to defend an approval for a record that you've worked on for years, you know, applying your litigation lens, making those key decisions early on, ensuring that the materials are clear, that can be understood by a court. It's much easier to defend that type of record than to defend an approval where no one on the project team gave really any thought to future litigation.
Dennis Mahony (09:32): Yeah. And to be clear, as you know, there are a large number of additional other areas in which the litigation can and should be applied. One which we haven't talked about is the application process itself and the steps to be taken in the application process, which ultimately get reviewed by a court. And it's just another example where the litigation lens can be applied very sparingly early on to great result in the long term.
So thank you everybody for joining us for this short discussion. We hope you found something useful in it. Be sure to check out our other videos in this series. And again, we appreciate you taking the time.
Le mois dernier, le Canada a publié sa première Stratégie industrielle de défense (la Stratégie), qui souligne l’engagement du Canada à développer une base industrielle de défense solide et à stimuler la croissance économique. Ces efforts pourraient aussi comprendre le renforcement de l’état de préparation à la biodéfense et aux contre-mesures médicales, ce qui pourrait constituer des débouchés pour le secteur canadien des sciences de la vie en raison de l’importance accordée aux capacités nationales en ce sens et de la nécessité d’atténuer les risques d’urgences sanitaires.
Comme indiqué dans les bulletins précédents, le quatrième pilier de la Stratégie est axé sur la « sécurisation des chaînes d’approvisionnement pour les intrants et les biens clés » par le renforcement de la production nationale et le stockage de ressources. L’accent est mis tout particulièrement sur les contre-mesures médicales, en précisant que nos « alliés ont établi un lien explicite entre l’état de préparation à la biodéfense et aux contre-mesures médicales et leur sécurité économique et nationale, en élaborant de nouvelles stratégies et de nouveaux mécanismes pour faire progresser ces travaux ». Les contre-mesures médicales désignent divers produits réglementés pouvant être utilisés pour protéger la population lors d’une situation d’urgence de grande ampleur, comme l’éclosion d’une maladie ou une attaque impliquant des armes chimiques, biologiques ou nucléaires. Il peut s’agir de vaccins, de médicaments thérapeutiques et produits biologiques, de dispositifs de tests diagnostiques, des équipements de protection individuelle ou industrielle, et d’autres dispositifs médicaux. Les contre-mesures médicales sont essentielles à la réduction et à l’atténuation des dommages lors d’une urgence de santé publique.
Pendant et après la pandémie de COVID-19, le Canada a mis en place plusieurs nouvelles voies réglementaires comme mécanismes d’accélération des approbations de produits médicaux, ce qui pourrait offrir au gouvernement des options pour déployer des contre-mesures médicales afin de faire face aux risques pour la santé publique. Au début de la pandémie, Santé Canada a émis diverses ordonnances provisoires pour permettre l’importation et la vente de médicaments et de dispositifs médicaux qui n’avaient pas eu l’approbation des voies réglementaires traditionnelles. Or, Santé Canada a plutôt fait confiance aux voies d’approbation réglementaire et de l’exemption de certaines exigences en homologation de produits des pays impliqués dans la transaction. Beaucoup de ces règles provisoires ont depuis été officiellement intégrées à la réglementation en vertu de la Loi sur les aliments et drogues et ont été appliquées bien après la COVID-19. Conformément au Règlement sur les aliments et drogues, Santé Canada tient à jour la Liste des maladies qui menacent la santé publique et utilisera une procédure d’autorisation modifiée pour les médicaments d’urgence de santé publique pouvant traiter les affections figurant sur la liste. De même, le Règlement sur les instruments médicaux a établi une liste d’instruments médicaux répondant à un besoin urgent de santé publique, ce qui permet à Santé Canada d’autoriser la commercialisation de ces instruments de manière accélérée. Ces outils réglementaires sont utilisés automatiquement quand une situation médicale présente un grand risque pour la santé publique au Canada et nécessite une action immédiate pour contrer ce risque.
La stratégie prévoit que le Canada adoptera une approche proactive en matière de planification en amont des crises sanitaires. Le gouvernement entend s’assurer que les produits médicaux sont déjà disponibles au Canada afin qu’ils puissent être distribués rapidement en cas d’urgence. D’autres modifications récentes au Règlement sur les aliments et drogues permettent de prépositionner au Canada tous les médicaments d’urgence en santé publique, ce qui signifie qu’ils peuvent être importés dans des installations d’entreposage canadiennes avant que leur mise sur le marché n’ait été autorisée. La Stratégie s’appuie sur ces fondements, en faisant référence à l’organisme existant Préparation aux crises sanitaires Canada (PCSC), un organisme opérationnel spécial au sein d’Innovation, Sciences et Développement économique Canada (ISDE), et à un nouveau Fonds des sciences de la vie, lesquels « collaborent avec des partenaires internationaux et de soutenir l’élaboration et la production de contre-mesures médicales ». PCSC supervise la Stratégie en matière de biofabrication et de sciences de la vie du Canada, qui vise à développer un secteur national des sciences de la vie fort et compétitif doté de capacités de biofabrication de pointe, en mettant l’accent sur la capacité à se préparer et à faire face aux futures priorités et crises sanitaires. Dans cette optique, il y aura des occasions pour les fabricants de nouer des collaborations de recherche et des accords commerciaux ou d’approvisionnement liés aux contre-mesures médicales financées par des programmes fédéraux.
Étroitement lié aux capacités nationales, le pilier III de la stratégie implique « Investissement ciblé pour renforcer un secteur canadien de la défense novateur », avec la promesse que le gouvernement fédéral « soutiendr[a] la recherche et le développement, protéger[a] la propriété intellectuelle, soutiendr[a] les petites et moyennes entreprises, investir[a] dans les compétences et la formation, et encourager[a] les exportations afin de créer un secteur de la défense agile et concurrentiel à l’échelle mondiale ». La nécessité de favoriser le développement de la propriété intellectuelle (PI) et la conservation des droits du Canada est mentionnée à plusieurs reprises dans la Stratégie. Par exemple, la Stratégie prévoit l’établissement de partenariats officiels avec l’industrie canadienne qui « [assureront] la propriété et le contrôle nationaux de la propriété intellectuelle (PI) et des capacités essentielles. » La Stratégie reconnaît l’immense talent des établissements canadiens et la précieuse recherche qui y est menée actuellement et qui est déjà financée par des subventions de recherche d’organismes tels que le Conseil de recherches en sciences naturelles et en génie et les Instituts de recherche en santé du Canada, et fait aussi référence à l’engagement de 1,6 milliard de dollars pour de nouveaux fonds de recherche dans le budget de 2025. Cette prise de conscience de la nécessité de promouvoir et de soutenir l’innovation au Canada laisse présager des possibilités de financement, notamment dans les domaines où le Canada accuse un retard en matière de production nationale et où des engagements d’investissement et de fabrication au Canada peuvent être pris.
Dans les prochains mois, nous prévoyons que le gouvernement du Canada publiera d’autres directives et des mesures de suivi. L’équipe de défense des conservateurs poursuivra sa couverture de perspectives sur la défense au Canada en publiant une analyse supplémentaire pour donner des précisions sur l’incidence de la Stratégie sur de multiples secteurs.